Valtrex Tablet, Film Coated
Product Images NDC 70518-2039

4 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Valtrex (NDC 70518-2039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Valacyclovir Hydrochloride Chemical Structure (Valtrex Spl Graphic 01)

Valacyclovir Hydrochloride Chemical Structure (Valtrex Spl Graphic 01)
Chemical structure of valacyclovir hydrochloride as depicted in the image. It shows the molecular arrangement and functional groups of the active ingredient in VALTREX 1 g film-coated tablets by RemedyRepack Inc.*
FDA Label Image

Mm1 (Valtrex 1g 70518 2039 00)

Mm1 (Valtrex 1g 70518 2039 00)
VALTREX 1 gram film-coated tablets packaging label showing a quantity of 10 tablets. The label includes the NDC number 70518-2039-00 and identifies RemedyRepack Inc. as the repackager. Manufacturer information lists GlaxoSmithKline, Research Triangle Park, NC. Storage instructions and a QR code are included on the label.*
FDA Label Image

Mm2 (Valtrex 1g 70518 2039 01)

Mm2 (Valtrex 1g 70518 2039 01)
VALTREX 1 g film-coated tablets package label. The label indicates a quantity of 14 tablets with NDC 70518-2039-01. The product is repackaged by RemedyRepack Inc. in Indiana, PA. It includes storage instructions and a manufacturing NDC from GlaxoSmithKline, Canada.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
VALTREX 1 g tablet film-coated oral medication label showing valacyclovir hydrochloride as the active ingredient. The package contains 10 tablets. Label includes NDC number 70518-2039-00, manufacturer GlaxoSmithKline, and repackager RemedyRepack Inc. Directions refer to the package insert. Storage instructions specify 20-25°C with permitted excursions to 15-30°C.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.